HomePPCB • NASDAQ
add
Propanc Biopharma Inc
Previous close
$1.06
Day range
$1.03 - $1.16
Year range
$1.03 - $9.36
Market cap
14.80M USD
Avg Volume
281.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.65M | 1,302.56% |
Net income | -4.07M | -1,035.45% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.65M | -1,302.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.09K | -42.67% |
Total assets | 19.63M | 27,028.87% |
Total liabilities | 5.73M | 48.66% |
Total equity | 13.91M | — |
Shares outstanding | 12.81M | — |
Price to book | 0.88 | — |
Return on assets | -43.23% | — |
Return on capital | -52.12% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -4.07M | -1,035.45% |
Cash from operations | -27.19K | 89.54% |
Cash from investing | — | — |
Cash from financing | 7.76K | -96.91% |
Net change in cash | -38.67K | -360.19% |
Free cash flow | 2.95M | 4,659.14% |
About
Founded
2007
Website
Employees
2
